BONH
UTHR icon

Bank of New Hampshire’s United Therapeutics UTHR Stock Holding History

Bank of New Hampshire’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$277K Sell
512
-14
-3% -$7.24K 0.06% 180
2026
Q2 		$285K Buy
526
+64
+14% +$36K 0.06% 181
2026
Q1 		$274K Buy
+462
New +$230K 0.06% 178
2025
Q1 		– Sell
-35
Closed -$12.3K – 471
2024
Q4 		$12.3K Hold
35
– – ﹤0.01% 385
2024
Q3 		$12.5K Hold
35
– – ﹤0.01% 387
2024
Q2 		$11.1K Hold
35
– – ﹤0.01% 410
2024
Q1 		$8.04K Hold
35
– – ﹤0.01% 429
2023
Q4 		$7.7K Hold
35
– – ﹤0.01% 429
2023
Q3 		$7.91K Hold
35
– – ﹤0.01% 425
2023
Q2 		$7.73K Buy
+35
New +$7.75K ﹤0.01% 440

Other funds holding UTHR

AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
BTC
Bank & Trust Company Litchfield, Illinois $159M AUM 30.15% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
SRS
Strong Retirement Solutions Silverdale, Washington $178M AUM 20.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Bank of New Hampshire's UTHR Position: Q3 2026 in Review

Bank of New Hampshire reduced its United Therapeutics (UTHR) stake by 2.7% in Q3 2026, selling an estimated $7.24K and leaving 512 shares worth $277K. The position accounts for 0.06% of the portfolio, ranked #180.

Bank of New Hampshire first reported a position in UTHR in Q2 2023 and has held it in 10 quarters since. The position peaked at $285K in Q2 2026. 17 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Bank of New Hampshire held 512 shares of United Therapeutics worth $277K as of Q3 2026.
  • Bank of New Hampshire sold 14 United Therapeutics shares in Q3 2026, an estimated $7.24K.
  • United Therapeutics made up 0.06% of Bank of New Hampshire's portfolio in Q3 2026, its #180 holding.
  • Bank of New Hampshire first reported a position in United Therapeutics in Q2 2023 and has held it in 10 quarters since.
  • Bank of New Hampshire's United Therapeutics position peaked at $285K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Bank of New Hampshire's 13F filing for Q3 2026, filed 6 Oct 2026.